Biogen Inc. (BIIB)

278.88
NASDAQ : Health Technology
Prev Close 278.70
Day Low/High 275.35 / 279.49
52 Wk Low/High 215.78 / 374.99
Avg Volume 1.76M
Exchange NASDAQ
Shares Outstanding 163.19M
Market Cap 43.79B
EPS 31.50
P/E Ratio 8.62
Div & Yield N.A. (N.A)
Alkermes Jumps on License Deal With Biogen -- Biotech Movers

Alkermes Jumps on License Deal With Biogen -- Biotech Movers

Alkermes and Biogen have inked a pact to develop and commercialize ALKS 8700, which is in Phase 3 development for treating relapsing forms of multiple sclerosis.

Biogen Is a new 'Hold' at Canaccord

Closing Bell: Stocks Surge on Strong Earnings Reports Across the Board

Closing Bell: Stocks Surge on Strong Earnings Reports Across the Board

Stocks closed confidently higher Tuesday.

Caterpillar, McDonald's and 3M Earnings Fuel Stock Rebound

Caterpillar, McDonald's and 3M Earnings Fuel Stock Rebound

Strong earnings from Dow components Caterpillar, McDonald's and 3M were on track to push the blue-chip index higher after a 0.23% decline on Monday.

Biogen Raised to Buy at Stifel

Biogen Shoots for More Upside

Biogen Shoots for More Upside

We like this name for higher prices into year-end.

Celgene and Biogen Analyst Moves Are 'Useless,' Jim Cramer Says

Celgene and Biogen Analyst Moves Are 'Useless,' Jim Cramer Says

Morgan Stanley analysts upgraded shares of Biogen and downgraded shares of Celgene over concerns of generic drug pressures. TheStreet's Jim Cramer called these moves "useless."

Inovio Rises On Phase 1 Data for Zika Vaccine -- Biotech Movers

Inovio Rises On Phase 1 Data for Zika Vaccine -- Biotech Movers

The Plymouth Meeting, Pa.-based firm said a Phase 1 study of Zika vaccine GLS-5700 'induced high levels of binding antibodies in 100% of participants.'

RBC Starts Biogen at Sector Perform

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Today's breakout move in the stock is a highlight of the surging sector.

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Today's breakout move in the stock is a highlight of the surging sector.

Biogen Raised to Buy at Goldman

Closing Bell: S&P 500 at Record; Senate Passes Motion to Proceed on Healthcare

Closing Bell: S&P 500 at Record; Senate Passes Motion to Proceed on Healthcare

The S&P 500 and Nasdaq end at records.

4 Stocks Warren Buffett Would Love

4 Stocks Warren Buffett Would Love

These disparate names seem to fit quite well with the investment approach of the Oracle of Omaha.

The Dow Binges on Earnings

The Dow Binges on Earnings

Get ready for another heavy earnings slate

Biogen Ready for a Big Bounce

Biogen Ready for a Big Bounce

The chart shows this stock has bottomed.

Cramer: The Rotation Out of Apple and Nvidia Can Happen Again Today

Cramer: The Rotation Out of Apple and Nvidia Can Happen Again Today

We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.

Cramer: Rally Is Earning Some Trust

Cramer: Rally Is Earning Some Trust

The market rally broadened out nicely today.

Charting the Biotechs

Charting the Biotechs

Time to revisit some stocks now that biotech has cooled.

The Good, the Bad and the Ugly (Mid-Afternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I have to prepare for my Tulane trip. So let's move to the abbreviated Monarc...

Midday Report: Amgen Leads Health Care Lower; U.S. Stocks Fall

Midday Report: Amgen Leads Health Care Lower; U.S. Stocks Fall

Stocks creep lower on Friday as a selloff in health care extends into its second day, this time led by Amgen shares.

Cramer: Confusion Reigns in This Market

Cramer: Confusion Reigns in This Market

Many want to undo what's been done, but not enough to send the market down.

Midday Report: Biogen Weighs on Health Care Stocks; U.S. Markets Fall

Midday Report: Biogen Weighs on Health Care Stocks; U.S. Markets Fall

Stocks give back earlier gains as a selloff in health care overshadows the Federal Reserve's decision a day earlier to raise interest rates.

Biogen downgraded at Leerink

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Cramer: Allergan Is the New Pharma Growth Stock

Cramer: Allergan Is the New Pharma Growth Stock

Jim Cramer compares Allergan's growth to other pharma stocks.

Biogen upgraded at Citi